Intelligent Bio Solutions Inc (INBS) Quote

$INBS Intelligent Bio begins dosing for non-invasive drug screening technology


https://finance.yahoo.com/news/intelligent-bio-begins-dosing-non-103309318.html

US-based company Intelligent Bio Solutions has completed patient screening and will start dosing and sampling in the pharmacokinetic (PK) study for its fingerprint drug screening technology.

The study is expected to support the planned 510(k) submission to the US FDA, intended for Q4 of this year. Intelligent Bio expects the study to complete recruitment by the end of June, with a review of the PK study results expected to be finalised by the end of next month.

The news comes on the heels of last week’s announcement of the company’s decision to shift its “operating structure from a UK-based model to a global framework”. Intelligent Bio plans to enter the US market with its fingerprint drug screening technology during H1 next year.

The Intelligent fingerprinting drug screening system detects the presence of specific drugs and their metabolites using fingerprint sweat analysis. Using a small, tamper-evident drug screening cartridge, the device can collect ten fingerprint sweat samples in under a minute.

The device aims to identify “current impairment”, not past use, as the test has a detection window of approximately 14–16 hours. The test is intended to be used to check for “fitness for duty” on the day and screen for common drugs of abuse such as cocaine, cannabis, methamphetamine and opiates.

The PK study aims to investigate the levels of opiates in fingerprint sweat compared with blood, oral fluid and urine samples. It will recruit 40 healthy adults and analyse the specimens using validated methods such as liquid chromatography, mass spectrometry and the Intelligent fingerprinting drug screening system.

The use of sweat testing as a method of drug detection is being developed by multiple companies. In February, the US Anti-Doping Agency partnered with Epicore to develop a sweat-sensing technology as a method of drug detection.

Epicore’s wearable sweat-collection device, Discovery Patch, comprises a wearable microfluidic patch that captures eccrine sweat directly from the skin during exercise, environmental exposure and pharmacologic modes of sweat induction. Sweat is transferred from the microfluidic patch to clean lab storage containers using a sweat extraction apparatus designed to rapidly collect and prepare sweat samples for biochemical analysis.

"Intelligent Bio begins dosing for non-invasive drug screening technology" was originally created and published by Medical Device Network, a GlobalData owned brand.

$INBS Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024

https://www.globenewswire.com/news-release/2024/06/06/2894659/0/en/Intelligent-Bio-Solutions-to-Participate-in-the-Sidoti-Small-Cap-Conference-on-June-12-13-2024.html

NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its management team will participate in the Sidoti Small-Cap Conference being held virtually June 12-13, 2024.

Presentation Details
Date: Wednesday, June 12, 2024
Time: 4:00 p.m. Eastern Time
Registration/Webcast Link: https://sidoti.zoom.us/webinar/register/WN_BB5QumW3TK2N56X7MOPjpw

For more information about the conference, or to schedule a one-on-one meeting with the INBS management team, please contact your Sidoti representative or email KCSA Strategic Communications at INBS@ksca.com.

$INBS - "management team will be presenting at the @SidotiResearch #SmallCap Conference at 4:00 pm ET on June 12, 2024.

Webcast Link: https://bit.ly/4bK8BQ7

For more info or to schedule a 1:1 with the INBS management team, please contact your Sidoti rep or email INBS@ksca.com"


$INBS' management team will be presenting at the @SidotiResearch #SmallCap Conference at 4:00 pm ET on June 12, 2024.

Webcast Link: https://t.co/W1mGTRbh9v

For more info or to schedule a 1:1 with the INBS management team, please contact your Sidoti rep or email INBS@ksca.com pic.twitter.com/wsusxthSeF— IBS Inc. (@ibs_inc_) June 6, 2024

$INBS - "Conventional drug tests can be intrusive and uncomfortable for both test takers and administrators. Fingerprint drug tests provide a dignified, hygienic, and cost-effective alternative for businesses. Discover more:
https://ibs.inc/2024/05/06/fingerprint-drug-tests-compared-to-urine-and-saliva/?utm_content=292069159&utm_medium=social&utm_source=twitter&hss_channel=tw-1172043611963187200
"

Conventional drug tests can be intrusive and uncomfortable for both test takers and administrators. Fingerprint drug tests provide a dignified, hygienic, and cost-effective alternative for businesses. Discover more: https://t.co/N9UnhKEeXW— IBS Inc. (@ibs_inc_) May 6, 2024

Stocks to Watch for Short Squeeze Potential: DJT, INBS, IMPP, HUBC, XXII

https://thestreetreports.com/stocks-to-watch-for-short-squeeze-potential-djt-inbs-impp-hubc-xxii/

Investors must stay alert to stocks poised for a short squeeze, given the significant gains typically seen during such events. Here’s a glimpse into five stocks potentially set for a short squeeze surge in the future.

Trump Media & Technology Corp. (NASDAQ: DJT) witnessed a stellar debut last week, followed by a more subdued performance. The short interest in DJT stock, reflecting borrowed shares anticipating a price drop, hit 4.93 million, representing 12.6% of available shares. Notably, the borrowing rate spiked to 500% due to limited shortable shares, hinting at potential short covering and a share price uptick in the future.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is attracting attention this week for potential short squeeze dynamics. As a leading provider of innovative medical tech, it posted impressive financials for Q2 and the six months ending Dec 31, 2023, with a 114% revenue increase YoY for Q2 and 337% for the six months. This growth is tied to its Intelligent Fingerprinting Drug Screening System and global expansion. The stock hit an intraday high of $11.70 and closing high of $6.76 in 2024. This low-float stock is currently oversold, and the short interest in INBS stock surged to 57.64% in the latest report is adding intrigue to INBS’s stock movement.

Imperial Petroleum Inc. (NASDAQ: IMPP) is worth monitoring due to its significant short interest. On February 13, IMPP announced its financial results for the fourth quarter and fiscal year ending December 31, 2023. The company’s revenues for the quarter were $29.9 million, down from $37.9 million in the previous year, while net income decreased from $13.8 million to $6.5 million. However, for the full fiscal year, revenues rose by $86.7 million to reach $183.7 million compared to the previous year.

HUB Cyber Security Ltd. (NASDAQ: HUBC) is a potential stock to watch this week, given its focus on confidential computer cyber security solutions and services. On April 5, HUBC made headlines by securing $8 million in new financing through a straight debt arrangement. This strategic financing is aimed at bolstering the company’s financial position and enhancing its future prospects, as stated in the news release.

22nd Century Group Inc. (NASDAQ: XXII), a company focused on reducing nicotine harm in tobacco products, disclosed its financial performance for the quarter ending December 31, 2023, on March 28. The company reported a decrease in net revenues from $10 million to $7.4 million compared to the prior-year period. The operating loss widened from $10.2 million to $14.2 million year-over-year. Despite this, the gross profit surged from $0.1 million to $7.8 million in the same period.

$INBS Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYC

https://www.globenewswire.com/news-release/2024/03/26/2852359/0/en/Intelligent-Bio-Solutions-to-Present-at-the-LD-Micro-Invitational-XIV-Investor-Conference-on-April-9-in-NYC.html

$INBS - Ladenburg Research Report: FDA Submission on Track for Submission in Q4-24; OUS Revenue Continues to Grow

https://ladenburg.bluematrix.com/sellside/EmailDocViewer?encrypt=2cbd38db-9256-42ca-b38c-9b7a3e678904&mime=pdf&co=Ladenburg&id=dror@ajocapital.com&source=mail

$INBS - "partners with
@ClianthaCRO
to conduct a #ClinicalStudy as Part of the #FDA 510(k) Pathway for the Intelligent Fingerprinting #DrugScreening System. This partnership marks significant #progress towards entry into the #US market."

$INBS partners with @ClianthaCRO to conduct a #ClinicalStudy as Part of the #FDA 510(k) Pathway for the Intelligent Fingerprinting #DrugScreening System. This partnership marks significant #progress towards entry into the #US market.

Read more: https://t.co/LETCKln0Bo— IBS Inc. (@ibs_inc_) February 28, 2024

Out of curiosity...what site gave 1.49....As of 2/7 it was around 2.1...

I'm been wondering if it's gone up at all

How many shares OS?

https://stocktwits.com/3227blake/message/561921113

https://stocktwits.com/3227blake/message/561918139

Tomorrow works for me too:)
Or Christmas . Doesn't matter. Seems like a great green investment.

I can do Tomorrows. LOL... Patience on this one is needed. Looks like a poolside day for me down here. 85 and sunny all day.-- Again lol.

what did Annie sing? "The Sun will come out...Tomorrow, tomorrow is only a day away..."

Lamb likes this stock. IMO lots of po-tential. If it doesn't make you rich, it'll make you "po'."

All the best to all INBS posters!

LC

INBS

Yea they sold and now reloading for the next run up

Mid-morning profit taking.

Silliness prevails.

LC

INBS

Bounce in the makings...

1.49 million outstanding shares... CRAZY LOW.....

Company Info: https://ibs.inc/who-we-are/

Baaaaaaackward looking. Go with the momo which shows an upward trend; even a possible breakout above $6.10-6.15. Above that price, the next resistance is at $11 +/- pps. IMO

LC

INBS

Oops... will look over there.

Up we go.. nice and steady

My first interest in this was from my back pain and they are on the cutting edge of helping people to become pain free again.

Share Profile:
Market Cap: Micro Cap
$11.62M

Shares Outstanding
2.15M

Shares held by Institutions
1.57%

Enterprise Value
$4.48M

My Babe is sensitive and will not forgive me if I forgot LOL...
This was move of a long term for me but it might blossom way before that. With Refinitiv Stock Reports Plus maintains a current price target of $9.30 for INBS. And its a BUY recommendation.

Oh no! say it ain't so!
"Babe" is a piggy in my playpen. You'd better send her an oink-a-gram and some mud puddles! and I mean, Wigglely Piggily!

Seriously--INBS doesn't look like they have very many shares in its float with the way the share price jumps around so quickly.

Just wondered if this is one of your legacy stocks or a quick buck? It looks/feels to me like it's a $25-$30 pps stock in the making. Few o/s shares, good product, moves on low volume. For me it's a trade.

Best of luck
LC

INBS

LOL... thanks, you just reminded me to send something to my Babe..

INBS: Won't you be my Valentine?

LC

INBS

Looks like the Pre market was a loading time..

Nice buy Lambchops.... Just grabbed another 300 just to round off my bucket full...

Got 1450 shares pre-market. Thanks for the suggestions.

LC

INBS

NEWS...acquisition: https://ih.advfn.com/stock-market/NASDAQ/intelligent-bio-solutions-INBS/stock-news/93270810/form-sc-13g-a-statement-of-acquisition-of-benefi

Yea I'm about to marry this stock... She's a keeper LOL.... I keep looking for something that's not right but it appears they run a very nice tight ship that is fill a great niche with their products.

Nice professionally done website. Lots of information there. https://ibs.inc/

lol yep.

Goodmorning all. Trying not to get emotional on IMBS but it's tough when there's so much upside :)

Interesting stock, Linkvest. Any more comments about it?
Maybe I'll nibble tomorrow morning on a little green grass here.

LC

INBS

MM's NSDQ, ARCX, and BATS are on the BID and ASK... They buying and sell a couple clicks at a time... They are the ones controlling this stock today.

Once this beast gets over the 6.10 the skies open up and its smooth sailing from there.

Well as long as one half is more profitable you'll do just fine lol

INBS wants to run so bad LOL... there are a lot of eyeballs watching this stock.... Hey my man, how it the weather in Louisiana right now. Warm?.... Been to New Orleans a few times over the years and always had fun. Great food.

We will see. I'm only wrong about half of the time. lol

Oh that would suck especially if it ran to a few dollars.. All you can do is watch LOL. I think they have a great niche market with a product can be replicated cheaply to resale with big time profit's. This is what every company hopes for...

On L2 you can see the BID is getting loaded up trying to get the cheapies now.. Volume is coming soon. Hold out folks and don't sell your shares until you see the whites in their eyes LOL...

Rightfully so. Slow and steady is better. I wouldn't mind a run up when I can actually take profits. Purchase agreement prohibits me from selling for a while :o. Good luck to you bud.

With only 1.49 million outstanding shares it moves like the wind with volume.

Yes... its fighting to stay in the 6's. Across the board it seems the MM's are walking stocks down today lol... But INBS is strong and increasing.

Strong buy by every measure

Refinitiv maintains still INBS is a BUY and with a current price target of $9.30 for INBS.

Hard to believe INBS only has 1.49 MILLION Shares Outstanding and Aw1416 probably owns half of them lol... A little news on this one could send this beast into stellar running mode..